Asiri Y, Moni S, Ramar M, Chidambaram K
    
    
    Pharmaceuticals (Basel). 2024; 17(11).
  
  
    PMID: 39598351
    
          PMC: 11597627.
    
          DOI: 10.3390/ph17111439.
      
 
                                  
  
    Hakansson J, Juhlin O, Hovannisyan A, Rosendahl J, Bogestal Y, Olmarker K
    
    
    J Orthop. 2023; 47:23-27.
  
  
    PMID: 38046450
    
          PMC: 10689205.
    
          DOI: 10.1016/j.jor.2023.11.012.
      
 
                                  
  
    Barton J, Londregan A, Alexander T, Entezari A, Covarrubias M, Waldman S
    
    
    Front Neurosci. 2023; 17:1272955.
  
  
    PMID: 38027512
    
          PMC: 10662325.
    
          DOI: 10.3389/fnins.2023.1272955.
      
 
                                  
  
    Varrassi G, Tamburin S, Zis P, Guardamagna V, Paladini A, Rekatsina M
    
    
    Cureus. 2023; 15(9):e44952.
  
  
    PMID: 37818524
    
          PMC: 10561699.
    
          DOI: 10.7759/cureus.44952.
      
 
                                  
  
    Panagiotides N, Zimprich F, Machold K, Schlager O, Muller M, Ertl S
    
    
    Int J Environ Res Public Health. 2023; 20(6).
  
  
    PMID: 36981826
    
          PMC: 10049708.
    
          DOI: 10.3390/ijerph20064918.
      
 
                              
              
                              
                                      
  High-throughput combined voltage-clamp/current-clamp analysis of freshly isolated neurons.
  
    Ghovanloo M, Tyagi S, Zhao P, Kiziltug E, Estacion M, Dib-Hajj S
    
    
    Cell Rep Methods. 2023; 3(1):100385.
  
  
    PMID: 36814833
    
          PMC: 9939380.
    
          DOI: 10.1016/j.crmeth.2022.100385.
      
 
                                          
                                                          
  Computational design of peptides to target Na1.7 channel with high potency and selectivity for the treatment of pain.
  
    Nguyen P, Nguyen H, Wagner K, Stewart R, Singh V, Thapa P
    
    
    Elife. 2022; 11.
  
  
    PMID: 36576241
    
          PMC: 9831606.
    
          DOI: 10.7554/eLife.81727.
      
 
                                          
                                                          
  Anatomical Analysis of Transient Potential Vanilloid Receptor 1 (+) and Mu-Opioid Receptor (+) Co-expression in Rat Dorsal Root Ganglion Neurons.
  
    Ma W, Sapio M, Manalo A, Maric D, Dougherty M, Goto T
    
    
    Front Mol Neurosci. 2022; 15:926596.
  
  
    PMID: 35875671
    
          PMC: 9302591.
    
          DOI: 10.3389/fnmol.2022.926596.
      
 
                                          
                                                          
  The Molecular Basis and Pathophysiology of Trigeminal Neuralgia.
  
    Chen Q, Yi D, Perez J, Liu M, Chang S, Barad M
    
    
    Int J Mol Sci. 2022; 23(7).
  
  
    PMID: 35408959
    
          PMC: 8998776.
    
          DOI: 10.3390/ijms23073604.
      
 
                                          
                                                          
  Translational Pharmacokinetic-Pharmacodynamic Modeling of NaV1.7 Inhibitor MK-2075 to Inform Human Efficacious Dose.
  
    Ballard J, Pall P, Vardigan J, Zhao F, Holahan M, Zhou X
    
    
    Front Pharmacol. 2022; 12:786078.
  
  
    PMID: 35002718
    
          PMC: 8740778.
    
          DOI: 10.3389/fphar.2021.786078.
      
 
                                          
                                                          
  Inhibition of the Nav1.7 Channel in the Trigeminal Ganglion Relieves Pulpitis Inflammatory Pain.
  
    Kwon M, Jung I, Cha M, Lee B
    
    
    Front Pharmacol. 2021; 12:759730.
  
  
    PMID: 34955831
    
          PMC: 8694709.
    
          DOI: 10.3389/fphar.2021.759730.
      
 
                                          
                                                          
  Brain injury and inflammation genes common to a number of neurological diseases and the genes involved in the genesis of GABAnergic neurons are altered in monoamine oxidase B knockout mice.
  
    Chen K, Palagashvili T, Hsu W, Chen Y, Tabakoff B, Hong F
    
    
    Brain Res. 2021; 1774:147724.
  
  
    PMID: 34780749
    
          PMC: 8638699.
    
          DOI: 10.1016/j.brainres.2021.147724.
      
 
                                          
                                                          
  Pharmacological Inhibition of the Voltage-Gated Sodium Channel Na1.7 Alleviates Chronic Visceral Pain in a Rodent Model of Irritable Bowel Syndrome.
  
    Jiang Y, Castro J, Blomster L, Agwa A, Maddern J, Schober G
    
    
    ACS Pharmacol Transl Sci. 2021; 4(4):1362-1378.
  
  
    PMID: 34423271
    
          PMC: 8369682.
    
          DOI: 10.1021/acsptsci.1c00072.
      
 
                                          
                                                          
  Cannabidiol and Sodium Channel Pharmacology: General Overview, Mechanism, and Clinical Implications.
  
    Ghovanloo M, Ruben P
    
    
    Neuroscientist. 2021; 28(4):318-334.
  
  
    PMID: 34027742
    
          PMC: 9344566.
    
          DOI: 10.1177/10738584211017009.
      
 
                                          
                                                          
  A mini-review: Bridging the gap between autism spectrum disorder and pain comorbidities.
  
    Brown C, Uy J, Singh K
    
    
    Can J Pain. 2021; 4(4):37-44.
  
  
    PMID: 33987518
    
          PMC: 7942773.
    
          DOI: 10.1080/24740527.2020.1775486.
      
 
                                          
                                                          
  Sodium channelopathies of skeletal muscle and brain.
  
    Mantegazza M, Cestele S, Catterall W
    
    
    Physiol Rev. 2021; 101(4):1633-1689.
  
  
    PMID: 33769100
    
          PMC: 8989381.
    
          DOI: 10.1152/physrev.00025.2020.
      
 
                                          
                                                          
  Comparative Analysis of Dorsal Root, Nodose and Sympathetic Ganglia for the Development of New Analgesics.
  
    Sapio M, Vazquez F, Loydpierson A, Maric D, Kim J, LaPaglia D
    
    
    Front Neurosci. 2021; 14:615362.
  
  
    PMID: 33424545
    
          PMC: 7793666.
    
          DOI: 10.3389/fnins.2020.615362.
      
 
                                          
                                                          
  Phosphorylation of a chronic pain mutation in the voltage-gated sodium channel Nav1.7 increases voltage sensitivity.
  
    Kerth C, Hautvast P, Korner J, Lampert A, Meents J
    
    
    J Biol Chem. 2020; 296:100227.
  
  
    PMID: 33361158
    
          PMC: 7948457.
    
          DOI: 10.1074/jbc.RA120.014288.
      
 
                                          
                                                          
  Controlling the "Opioid Epidemic": A Novel Chemical Entity (NCE) to Reduce or Supplant Opiate Use for Chronic Pain.
  
    Tabakoff B, Hoffman P
    
    
    J Psychiatr Brain Sci. 2020; 5.
  
  
    PMID: 33117893
    
          PMC: 7591148.
    
          DOI: 10.20900/jpbs.20200022.
      
 
                                          
                                                          
  Application of Pharmacokinetic-Pharmacodynamic Modeling to Inform Translation of In Vitro NaV1.7 Inhibition to In Vivo Pharmacological Response in Non-human Primate.
  
    Ballard J, Pall P, Vardigan J, Zhao F, Holahan M, Kraus R
    
    
    Pharm Res. 2020; 37(10):181.
  
  
    PMID: 32888082
    
          PMC: 7473964.
    
          DOI: 10.1007/s11095-020-02914-9.